Outline
| Company name |
Life Science Institute, Inc. |
|---|---|
| Head office | THE KAITEKI Building, 13‐4 Uchikanda 1‐chome, Chiyoda‐ku, Tokyo 101‐0047 |
| Date of establishment | April 1, 2014 |
| Paid-in capital | 9,250 million yen |
| Line of business (consolidated) | Health and medical ICT, advanced medication, and drug development & manufacturing solutions |
| Sales revenue（Consolidated） | 38.3 billion（FY2019） |
| Employees (Consolidated) | 1,817(As of March 31, 2020) |
